Alkermes (NASDAQ: ALKS) reported Q4 EPS of $0.29, $0.12 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $384.5 million versus the consensus estimate of $383.07 million.

GUIDANCE:

Alkermes sees FY2026 revenue of $1.73-1.84 billion, versus the consensus of $1.83 billion.

For earnings history and earnings-related data on Alkermes (ALKS) click here.